2026/03/13 by Ana-Maria Caldaruse, Hannah M. Baumann, David L. Mobley · 1 voice
Computer Science · Biochemistry, Genetics and Molecular Biology · #Computational Drug Discovery Methods #Protein Structure and Dynamics #Chemical Synthesis and Analysis
paper · pdf · doi:10.1021/acs.jcim.5c03091
openalex publication_date 2026/03/13 · openalex created_date 2026/03/14 · openalex updated_date 2026/07/12
Fragment-based drug discovery (FBDD) is a widely used strategy in early-stage drug development, but accurately predicting the binding affinities of fragments and their elaborated analogs poses unique computational challenges. These difficulties arise from weak binding affinities, diverse chemical scaffolds, and limited structural overlap between fragments and their optimized derivatives. While several free-energy methods exist, few are tailored to the specific requirements of FBDD. In this study, we evaluate the Separated Topologies (SepTop) approach for modeling fragment-based transformations, including fragment merging and linking. Using retrospective data sets from Cyclophilin D and SARS-CoV-2 Macrodomain 1, we demonstrate that SepTop can recover experimental binding affinities with good accuracy across both fragment and lead-like compounds. These results support SepTop's suitability for fragment optimization and highlight its potential to extend the reach of binding free-energy calculations into earlier stages of drug discovery.